Peters Richard (CIK 1697628) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy APRE (3,135 shares), Sell KANT (101,891 shares), Buy KANT (12,500 shares), Sell KANT (4,706 shares), Buy KANT (6,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Aprea Therapeutics, Inc. (APRE) | Director | Buy | 3,135 | $0 |
| 2025-07-02 | KINETA, INC./DE (KANT) | Director | Sell | 101,891 | $0 |
| 2025-06-25 | KINETA, INC./DE (KANT) | Director | Buy | 12,500 | $7,625 |
| 2025-06-25 | KINETA, INC./DE (KANT) | Director | Sell | 4,706 | $1,224 |
| 2025-06-25 | KINETA, INC./DE (KANT) | Director | Buy | 6,000 | $0 |
| 2025-06-09 | Aprea Therapeutics, Inc. (APRE) | Director | Buy | 1,045 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17